Redx Pharma
Stock Forecast, Prediction & Price Target
Redx Pharma Financial Estimates
Redx Pharma Revenue Estimates
Redx Pharma EBITDA Estimates
Redx Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2021 | 9/30/2022 | 9/30/2023 | 9/30/2025 | |||
Revenue
% change YoY
| £10.03M N/A | £18.69M 86.24% | £4.20M -77.51% | Avg: £1.25M Low: £1.13M High: £1.36M avg. -70.21% | |||
Net Income
% change YoY
| £-21.57M N/A | £-18.00M 16.55% | £-33.15M -84.14% | Avg: £-49.3M Low: £-47.37M High: £-37.48M avg. -48.69% | |||
EBITDA
% change YoY
| £-19.09M N/A | £-15.19M 20.45% | £-32.02M -110.78% | Avg: £-1.20M Low: £-1.31M High: £-1.09M avg. 96.23% | |||
EPS
% change YoY
| -$0.08 N/A | -$0.06 27.22% | -$0.1 -61.76% | Avg: -$0.13 Low: -$0.14 High: -$0.11 avg. -27.97% | |||
Operating Expenses
% change YoY
| £29.78M N/A | £37.25M 25.09% | £35.18M -5.55% | Avg: £784.83K Low: £714.52K High: £855.14K avg. -97.76% | |||
FAQ
What is Redx Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -48.69% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -47.37M, average is -49.3M and high is -37.48M.
What is Redx Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -70.21% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is £1.13M, average is £1.25M and high is £1.36M.
What is Redx Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -27.97% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.14, average is -$0.13 and high is £-0.11.